{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:32:13Z","timestamp":1782513133049,"version":"3.54.5"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.bbi.2018.01.005","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T09:12:19Z","timestamp":1517389939000},"page":"470-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Sustained reversal of central neuropathic pain induced by a single intrathecal injection of adenosine A2A receptor agonists"],"prefix":"10.1016","volume":"69","author":[{"given":"Andrew J.","family":"Kwilasz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Wieseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Loram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Favret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McFadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra","family":"Springer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Falci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayson","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven F.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda R.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2018.01.005_b0005","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.neuroscience.2004.01.004","article-title":"The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse","volume":"124","author":"Abraham","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2018.01.005_b0010","doi-asserted-by":"crossref","first-page":"e00134","DOI":"10.1002\/prp2.134","article-title":"The discovery of a selective and potent A2a agonist with extended lung retention","volume":"3","author":"Astrand","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bbi.2018.01.005_b0015","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00702-005-0300-x","article-title":"Evidence-based pharmacological treatment of neuropathic pain syndromes","volume":"112","author":"Beniczky","year":"2005","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.bbi.2018.01.005_b0020","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1089\/neu.1999.16.851","article-title":"Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats","volume":"16","author":"Bethea","year":"1999","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bbi.2018.01.005_b0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0304-3959(01)00354-2","article-title":"A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats","volume":"94","author":"Chacur","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.bbi.2018.01.005_b0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbi.2018.01.005_b0035","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1096\/fj.11-201541","article-title":"Controlling murine and rat chronic pain through A3 adenosine receptor activation","volume":"26","author":"Chen","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.bbi.2018.01.005_b0040","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/rns.2011.020","article-title":"Adenosine 2A receptor: a crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury","volume":"22","author":"Dai","year":"2011","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.bbi.2018.01.005_b0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.physbeh.2007.05.031","article-title":"Modulation of glial cell functions by adenosine receptors","volume":"92","author":"Dare","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbi.2018.01.005_b0050","doi-asserted-by":"crossref","first-page":"e52566","DOI":"10.1371\/journal.pone.0052566","article-title":"Adenosine A2A receptor deficiency up-regulates cystatin F expression in white matter lesions induced by chronic cerebral hypoperfusion","volume":"7","author":"Duan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2018.01.005_b0055","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jpain.2013.12.007","article-title":"Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain","volume":"15","author":"Ellis","year":"2014","journal-title":"J. Pain"},{"key":"10.1016\/j.bbi.2018.01.005_b0060","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.1021\/jm900538v","article-title":"Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase","volume":"52","author":"El-Tayeb","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbi.2018.01.005_b0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clim.2011.03.002","article-title":"Targeting iNKT cells for the treatment of sickle cell disease","volume":"140","author":"Field","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbi.2018.01.005_b0070","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003717","article-title":"Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis","volume":"4","author":"Flogel","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbi.2018.01.005_b0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pneurobio.2007.07.005","article-title":"Aspects of the general biology of adenosine A2A signaling","volume":"83","author":"Fredholm","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbi.2018.01.005_b0080","first-page":"73","article-title":"Selective adenosine A(2a) receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma","volume":"24","author":"Genovese","year":"2010","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.bbi.2018.01.005_b0085","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1213\/ane.0b013e318173251f","article-title":"Expression of adenosine A2A receptors in the rat lumbar spinal cord and implications in the modulation of N-methyl-d-aspartate receptor currents","volume":"106","author":"Guntz","year":"2008","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.bbi.2018.01.005_b0090","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.neuroscience.2009.03.055","article-title":"Remote astrocytic and microglial activation modulates neuronal hyperexcitability and below-level neuropathic pain after spinal injury in rat","volume":"161","author":"Gwak","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2018.01.005_b0095","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3758\/BF03201438","article-title":"Efficient estimation of sensory thresholds","volume":"18","author":"Harvey","year":"1986","journal-title":"Behav. Res. Methods Inst. Comp."},{"key":"10.1016\/j.bbi.2018.01.005_b0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.it.2003.11.003","article-title":"Adenosine: an endogenous regulator of innate immunity","volume":"25","author":"Hasko","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbi.2018.01.005_b0105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1189\/jlb.0607359","article-title":"A2A receptors in inflammation and injury: lessons learned from transgenic animals","volume":"83","author":"Hasko","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbi.2018.01.005_b0110","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1096\/fj.201601307R","article-title":"CD73-derived adenosine and tenascin-C control cytokine production by epicardium-derived cells formed after myocardial infarction","volume":"31","author":"Hesse","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.bbi.2018.01.005_b0115","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/sc.2009.194","article-title":"Adenosine A1 receptor agonists reduce hyperalgesia after spinal cord injury in rats","volume":"48","author":"Horiuchi","year":"2010","journal-title":"Spinal Cord"},{"key":"10.1016\/j.bbi.2018.01.005_b0120","doi-asserted-by":"crossref","first-page":"e20934","DOI":"10.1371\/journal.pone.0020934","article-title":"A new drug design targeting the adenosinergic system for Huntington's disease","volume":"6","author":"Huang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2018.01.005_b0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.expneurol.2008.07.016","article-title":"Gliopathy ensures persistent inflammation and chronic pain after spinal cord injury","volume":"214","author":"Hulsebosch","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2018.01.005_b0130","doi-asserted-by":"crossref","first-page":"e18633","DOI":"10.1371\/journal.pone.0018633","article-title":"Ibudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cells","volume":"6","author":"Kiebala","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2018.01.005_b0135","doi-asserted-by":"crossref","first-page":"13435","DOI":"10.1523\/JNEUROSCI.3257-09.2009","article-title":"Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord","volume":"29","author":"Kigerl","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2018.01.005_b0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(02)02789-9","article-title":"Propentofylline protects beta-amyloid protein-induced apoptosis in cultured rat hippocampal neurons","volume":"458","author":"Koriyama","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2018.01.005_b0145","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1084\/jem.20061097","article-title":"Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation","volume":"203","author":"Lappas","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2018.01.005_b0150","doi-asserted-by":"crossref","first-page":"14015","DOI":"10.1523\/JNEUROSCI.3447-09.2009","article-title":"Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain","volume":"29","author":"Loram","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2018.01.005_b0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbi.2013.06.004","article-title":"Intrathecal injection of adenosine 2A receptor agonists reversed neuropathic allodynia through protein kinase (PK)A\/PKC signaling","volume":"33","author":"Loram","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2018.01.005_b0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbi.2018.01.005_b0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrn2533","article-title":"Pathological and protective roles of glia in chronic pain","volume":"10","author":"Milligan","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2018.01.005_b0170","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1523\/JNEUROSCI.21-08-02808.2001","article-title":"Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines","volume":"21","author":"Milligan","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2018.01.005_b0175","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/j.1460-9568.2005.04057.x","article-title":"Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10","volume":"21","author":"Milligan","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbi.2018.01.005_b0180","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pain.2006.07.009","article-title":"Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain","volume":"126","author":"Milligan","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.bbi.2018.01.005_b0185","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1525-1403.2012.00462.x","article-title":"Spinal interleukin-10 therapy to treat peripheral neuropathic pain","volume":"15","author":"Milligan","year":"2012","journal-title":"Neuromodulation"},{"key":"10.1016\/j.bbi.2018.01.005_b0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1471-2334-8-141","article-title":"An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models","volume":"8","author":"Moore","year":"2008","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bbi.2018.01.005_b0195","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1042\/BJ20050888","article-title":"Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction","volume":"391","author":"Murphree","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbi.2018.01.005_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2017.06.007","article-title":"synergistic interaction between dexmedetomidine and ulinastatin against vincristine-induced neuropathic pain in rats","author":"Nie","year":"2017","journal-title":"J. Pain"},{"key":"10.1016\/j.bbi.2018.01.005_b0205","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2018.01.005_b0210","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0002-9440(10)63698-X","article-title":"An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors","volume":"163","author":"Pinhal-Enfield","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbi.2018.01.005_b0215","doi-asserted-by":"crossref","first-page":"10714","DOI":"10.1523\/JNEUROSCI.1922-07.2007","article-title":"CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells","volume":"27","author":"Ponomarev","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2018.01.005_b0220","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003346","article-title":"Adenosine formed by CD73 on T cells inhibits cardiac inflammation and fibrosis and preserves contractile function in transverse aortic constriction-induced heart failure","volume":"10","author":"Quast","year":"2017","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.bbi.2018.01.005_b0225","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1111\/j.1476-5381.1995.tb15057.x","article-title":"The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurones in the anaesthetized rat","volume":"116","author":"Reeve","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2018.01.005_b0230","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0301-0082(03)00050-9","article-title":"Adenosine in the spinal cord and periphery: release and regulation of pain","volume":"69","author":"Sawynok","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbi.2018.01.005_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(97)01110-2","article-title":"Adenosine A3 receptor activation produces nociceptive behaviour and edema by release of histamine and 5-hydroxytryptamine","volume":"333","author":"Sawynok","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2018.01.005_b0240","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.immuni.2013.02.012","article-title":"Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus","volume":"38","author":"Shechter","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.bbi.2018.01.005_b0245","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3959(99)00023-8","article-title":"Pain report and the relationship of pain to physical factors in the first 6 months following spinal cord injury","volume":"81","author":"Siddall","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.bbi.2018.01.005_b0250","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0304-3959(02)00452-9","article-title":"A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury","volume":"103","author":"Siddall","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.bbi.2018.01.005_b0255","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/gt.2009.79","article-title":"Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain","volume":"16","author":"Sloane","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbi.2018.01.005_b0260","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/gt.2009.21","article-title":"Long-term control of neuropathic pain in a non-viral gene therapy paradigm","volume":"16","author":"Sloane","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbi.2018.01.005_b0265","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1682\/JRRD.2008.03.0048","article-title":"Early microglial inhibition preemptively mitigates chronic pain development after experimental spinal cord injury","volume":"46","author":"Tan","year":"2009","journal-title":"J. Rehabil. Res. Dev."},{"key":"10.1016\/j.bbi.2018.01.005_b0270","doi-asserted-by":"crossref","first-page":"H348","DOI":"10.1152\/ajpheart.00740.2005","article-title":"Contractile effects of adenosine A1 and A2A receptors in isolated murine hearts","volume":"290","author":"Tikh","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbi.2018.01.005_b0275","doi-asserted-by":"crossref","first-page":"e54195","DOI":"10.1371\/journal.pone.0054195","article-title":"A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats","volume":"8","author":"Vincenzi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2018.01.005_b0280","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbi.2006.10.011","article-title":"Norman Cousins Lecture. Glia as the \u201cbad guys\u201d: implications for improving clinical pain control and the clinical utility of opioids","volume":"21","author":"Watkins","year":"2007","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.bbi.2018.01.005_b0285","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1089\/neu.2010.1311","article-title":"Below level central pain induced by discrete dorsal spinal cord injury","volume":"2","author":"Wieseler","year":"2010","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bbi.2018.01.005_b0290","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.bbi.2006.07.004","article-title":"A novel immune-to-CNS communication pathway: cells of the meninges surrounding the spinal cord CSF space produce proinflammatory cytokines in response to an inflammatory stimulus","volume":"21","author":"Wieseler-Frank","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2018.01.005_b0295","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pain.2008.10.007","article-title":"Neuropathic pain and primary somatosensory cortex reorganization following spinal cord injury","volume":"141","author":"Wrigley","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.bbi.2018.01.005_b0300","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1471-4159.2012.07807.x","article-title":"Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis","volume":"123","author":"Yao","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2018.01.005_b0305","first-page":"1015","article-title":"Ibudilast prevents oligodendroglial excitotoxicity","volume":"49","author":"Yoshioka","year":"1997","journal-title":"No To Shinkei"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159118300047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159118300047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:53:56Z","timestamp":1760169236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159118300047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":61,"alternative-id":["S0889159118300047"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2018.01.005","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained reversal of central neuropathic pain induced by a single intrathecal injection of adenosine A2A receptor agonists","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2018.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}